The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  BioMarin Pharmaceutical Inc. (BMRN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Kuvan sales...

Jan 22, 2008 05:16 AM GMT
Pict0062
Return Risk
-12.06% MID
Analyst

Biomarin has had a huge upturn do to FDA approval of Kuvan. Even with this higher price I still remain bearish. If insurance companies approve Kuvan, and if it succeeds in treatment of PKU. We should still see solid growth with the combination of solid sales of Naglazyme and Aldurazyme.


BMRN:  This call was made on 01/22/08 @ $35.19
Rating:   Positive   $35.19 (01/22/08)
Closed:   01/25/2008 @ $36.12 (+2.64% in 3 days)
Target:   $50.00 (+42.09%) in > one year


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.56% 370
2 Gerald Greene 18.14 +69.43% 207
3 stockmarketfunding.com 17.66 +25.71% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.75% 34


POPULAR STOCKS
Symbol Company Name Sentiment
YHOO Yahoo! Inc
DELL Dell Inc
GOOG Google Inc
LEH Lehman Brothers Holdings Inc
MA MasterCard Inc
NVDA NVIDIA Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
BioMarin Pharmaceutical Inc. (BMRN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
89.0%
Top:
50.0%




Latest Picks by Drew
Symbol SP Sentiment Rating Return Since
NVDA Positive -42.53% 05/22/08
C Positive -80.28% 05/22/08
PX Positive +7.67% 01/25/08
SRSR Positive +425.00% 01/24/08
RGEN N/A Positive -20.52% 01/22/08

View All >
   
Drew previously rated BMRN
Positive +0.00% Bullish on BMRN ...
01/25/2008
1
Positive +0.00% Bullish on BMRN ...
01/21/2008
0
Positive +0.00% Bullish on BMRN ...
01/21/2008
0





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch